Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates
-
Review Comparative Study
The stool DNA test: an emerging technology in colorectal cancer screening.
The stool DNA test is considered an emerging technology in screening for colorectal cancer. The stool DNA test detects DNA markers which are shed from cells of premalignant adenomas and cancers into the stool. Potentially, both preclinical and clinical colorectal cancer may be detected. ⋯ Some limitations of the stool DNA test include the need for clinical studies in average-risk populations and marker refinement. An automated testing system may help reduce costs and turnaround times. Despite recognized limitations, the stool DNA test is a promising new diagnostic tool with the potential to improve effectiveness of colorectal cancer screening.
-
Comparative Study
Development of the Society of Gastroenterology Nurses and Associates Minimum Data Set: an evidence-based resource.
The Society for Gastroenterology Nurses and Associates (SGNA) has developed a Minimum Data Set identifying the essential elements necessary to document delivery of patient care in the gastrointestinal endoscopic setting. Standardized information, such as a minimum data set, for facilitating communication among practitioners is believed to enhance patient outcomes. The SGNA Minimum Data Set was developed for "public" use to facilitate quality patient outcomes and to enhance the education, research, and clinical practice of GI nurses. ⋯ Focus groups with members from around the U. S. verified the validity of the Minimum Data Set. The SGNA Minimum Data Set can be used by healthcare institutions, industry, and individuals to facilitate the capture and analysis of standardized data for the purpose of improving GI patient outcomes and enhancing delivery of nursing care.